These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 8479116

  • 1. Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms.
    Dworkin LD, Benstein JA, Parker M, Tolbert E, Feiner HD.
    Kidney Int; 1993 Apr; 43(4):808-14. PubMed ID: 8479116
    [Abstract] [Full Text] [Related]

  • 2. Effects of nifedipine and enalapril on glomerular structure and function in uninephrectomized SHR.
    Dworkin LD, Feiner HD, Parker M, Tolbert E.
    Kidney Int; 1991 Jun; 39(6):1112-7. PubMed ID: 1895665
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic implications of converting-enzyme inhibitors in renal disease.
    Anderson S, Brenner BM.
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):81-7. PubMed ID: 3037894
    [Abstract] [Full Text] [Related]

  • 4. Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency.
    Mackie FE, Meyer TW, Campbell DJ.
    Kidney Int; 2002 Feb; 61(2):555-63. PubMed ID: 11849396
    [Abstract] [Full Text] [Related]

  • 5. Combined effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on renal injury.
    Bakris GL, Griffin KA, Picken MM, Bidani AK.
    J Hypertens; 1997 Oct; 15(10):1181-5. PubMed ID: 9350593
    [Abstract] [Full Text] [Related]

  • 6. Effects of antihypertensive drugs on autoregulation of RBF and glomerular capillary pressure in SHR.
    Kvam FI, Ofstad J, Iversen BM.
    Am J Physiol; 1998 Oct; 275(4):F576-84. PubMed ID: 9755129
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat.
    Anderson S, Rennke HG, Brenner BM.
    J Clin Invest; 1986 Jun; 77(6):1993-2000. PubMed ID: 3011863
    [Abstract] [Full Text] [Related]

  • 8. The role of intraglomerular pressure in the initiation and progression of renal disease.
    Anderson S, Brenner BM.
    J Hypertens Suppl; 1986 Dec; 4(5):S236-8. PubMed ID: 3033176
    [Abstract] [Full Text] [Related]

  • 9. "Pulse" treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension.
    Ishiguro K, Hayashi K, Sasamura H, Sakamaki Y, Itoh H.
    Hypertension; 2009 Jan; 53(1):83-9. PubMed ID: 19047581
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.
    Perico N, Amuchastegui CS, Malanchini B, Bertani T, Remuzzi G.
    Exp Nephrol; 1994 Jan; 2(4):220-8. PubMed ID: 8069658
    [Abstract] [Full Text] [Related]

  • 11. Urinary transforming growth factor-beta (TGF-beta) excretion and renal production of TGF-beta in rats with subtotal renal ablation: effect of enalapril and nifedipine.
    Monteiro de Freitas AS, Coimbra TM, Costa RS, Baroni EA.
    Nephron; 1998 Jan; 78(3):302-9. PubMed ID: 9546691
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.
    Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G.
    J Clin Invest; 1990 Feb; 85(2):541-9. PubMed ID: 1688888
    [Abstract] [Full Text] [Related]

  • 13. Reversing glomerular hypertension stabilizes established glomerular injury in renal ablation.
    Meyer TW, Anderson S, Rennke HG, Brenner BM.
    J Hypertens Suppl; 1986 Dec; 4(5):S239-41. PubMed ID: 3033177
    [Abstract] [Full Text] [Related]

  • 14. Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomerular injury.
    Tolins JP, Raij L.
    Hypertension; 1990 Oct; 16(4):452-61. PubMed ID: 2210813
    [Abstract] [Full Text] [Related]

  • 15. A selective cyclooxygenase-2 inhibitor decreases proteinuria and retards progressive renal injury in rats.
    Wang JL, Cheng HF, Shappell S, Harris RC.
    Kidney Int; 2000 Jun; 57(6):2334-42. PubMed ID: 10844603
    [Abstract] [Full Text] [Related]

  • 16. Antihypertensive therapy must control glomerular hypertension to limit glomerular injury.
    Anderson S, Rennke HG, Brenner BM.
    J Hypertens Suppl; 1986 Dec; 4(5):S242-4. PubMed ID: 3553475
    [Abstract] [Full Text] [Related]

  • 17. Converting enzyme inhibitor therapy limits progressive glomerular injury in rats with renal insufficiency.
    Meyer TW, Anderson S, Rennke HG, Brenner BM.
    Am J Med; 1985 Sep 27; 79(3C):31-6. PubMed ID: 2996344
    [Abstract] [Full Text] [Related]

  • 18. Salt restriction inhibits renal growth and stabilizes injury in rats with established renal disease.
    Dworkin LD, Benstein JA, Tolbert E, Feiner HD.
    J Am Soc Nephrol; 1996 Mar 27; 7(3):437-42. PubMed ID: 8704110
    [Abstract] [Full Text] [Related]

  • 19. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH, Reams GP.
    J Am Soc Nephrol; 1990 Nov 27; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of the effects of inhibition of angiotensin converting enzyme with enalapril in dogs with induced chronic renal insufficiency.
    Brown SA, Finco DR, Brown CA, Crowell WA, Alva R, Ericsson GE, Cooper T.
    Am J Vet Res; 2003 Mar 27; 64(3):321-7. PubMed ID: 12661873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.